Now showing items 1-9 of 9

    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2017-03-28)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or morality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-02-06)
      Vaccine, vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaian, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy, (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-06-25)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-10-06)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Barta, John R.; Berghman, Luc; Shivaramaiah, Srichaitanya; Faulkner, Olivia B.; Bielke, Lisa; Hargis, Billy (United States. Patent and Trademark Office; Texas A&M University. Libraries, 6/21/2022)
      Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
    • Arntzen, Charles J.; Mason, Hugh S.; Tariq, Haq A.; Clements, John D. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-05-28)
      The oral antigens and adjuvants of the present invention are produced in transgenic plants and then administered through the consumption of the transgenic plant. DNA sequences both natural and synthetic encoding for the ...
    • Ficht, Allison R.; Carson, Kenneth; Sheffield, Cynthia; Waite, John Herbert (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-23)
      The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended ...
    • Berghman, Luc; Bottje, Walter; Hargis, Billy; Layton, Sherryll (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)
      Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...
    • Berghman, Luc; Bottje, Walter; Hargis, Billy; Layton, Sherryll (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-03-13)
      Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...